peptide Search Results


c peptide  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology c peptide
C Peptide, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c peptide/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
c peptide - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
buffer  (Boster Bio)
93
Boster Bio buffer
Buffer, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/buffer/product/Boster Bio
Average 93 stars, based on 1 article reviews
buffer - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
neoantigen peptides  (Biosynth Carbosynth)
91
Biosynth Carbosynth neoantigen peptides
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
Neoantigen Peptides, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/neoantigen peptides/product/Biosynth Carbosynth
Average 91 stars, based on 1 article reviews
neoantigen peptides - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
rabbit peptide antibody  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc rabbit peptide antibody
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
Rabbit Peptide Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit peptide antibody/product/Cell Signaling Technology Inc
Average 93 stars, based on 1 article reviews
rabbit peptide antibody - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
tap1  (Proteintech)
94
Proteintech tap1
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
Tap1, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tap1/product/Proteintech
Average 94 stars, based on 1 article reviews
tap1 - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
rotein ll 37 elisa kit  (Cusabio)
92
Cusabio rotein ll 37 elisa kit
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
Rotein Ll 37 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rotein ll 37 elisa kit/product/Cusabio
Average 92 stars, based on 1 article reviews
rotein ll 37 elisa kit - by Bioz Stars, 2026-04
92/100 stars
  Buy from Supplier
amyloid β  (ProSci Incorporated)
93
ProSci Incorporated amyloid β
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
Amyloid β, supplied by ProSci Incorporated, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/amyloid β/product/ProSci Incorporated
Average 93 stars, based on 1 article reviews
amyloid β - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
human pd 1 antibodies  (Bio X Cell)
95
Bio X Cell human pd 1 antibodies
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
Human Pd 1 Antibodies, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human pd 1 antibodies/product/Bio X Cell
Average 95 stars, based on 1 article reviews
human pd 1 antibodies - by Bioz Stars, 2026-04
95/100 stars
  Buy from Supplier
csbe08210h kit  (Cusabio)
93
Cusabio csbe08210h kit
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
Csbe08210h Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/csbe08210h kit/product/Cusabio
Average 93 stars, based on 1 article reviews
csbe08210h kit - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
14887 1 ap  (Proteintech)
94
Proteintech 14887 1 ap
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
14887 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/14887 1 ap/product/Proteintech
Average 94 stars, based on 1 article reviews
14887 1 ap - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
mouse monoclonal antibody moab  (Biosensis ltd)
94
Biosensis ltd mouse monoclonal antibody moab
(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of <t>neoantigen/mHA</t> prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.
Mouse Monoclonal Antibody Moab, supplied by Biosensis ltd, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse monoclonal antibody moab/product/Biosensis ltd
Average 94 stars, based on 1 article reviews
mouse monoclonal antibody moab - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier
hepcidin antimicrobial peptide antibody  (Novus Biologicals)
94
Novus Biologicals hepcidin antimicrobial peptide antibody
A) Schematic depicting pre-clinical trial workflow. B) Brightfield images of tumors isolated from vehicle and LDN214117 treated mice. C) Mean tumor volume from mice treated with vehicle (6 mice/group) and LDN214117 (7 mice/group). D) Graph depicting mean tumor weight from vehicle and LDN214117 treated mice. E) Western blot to assess BMP6 and <t>hepcidin</t> expression level in tumors from vehicle and LDN214117-treated mice. F) Representative images of immunohistochemistry for BMP6 and Hepcidin on tumor sections from mice treated with vehicle or LDN214117. F) Model depicting mechanism of altered iron homeostasis in LKB1-mutant tumor cells.
Hepcidin Antimicrobial Peptide Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hepcidin antimicrobial peptide antibody/product/Novus Biologicals
Average 94 stars, based on 1 article reviews
hepcidin antimicrobial peptide antibody - by Bioz Stars, 2026-04
94/100 stars
  Buy from Supplier

Image Search Results


(A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of neoantigen/mHA prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.

Journal: Cancer immunology research

Article Title: Machine-learning prediction of tumor antigen immunogenicity in the selection of therapeutic epitopes

doi: 10.1158/2326-6066.CIR-19-0155

Figure Lengend Snippet: (A) Number of MHC class I and II neoantigens/mHA per tumor model contained within the study. (B) Schematic of neoantigen/mHA prediction and ELISpot validation workflow. (C) Summary of the major classes of peptide-intrinsic features identified for each antigen, including amino acid sequence and characteristics at I) each absolute position, II) each relative site, III) the mutation position, and IV) the start, middle, and end of each peptide. Red boxes around columns in I) demonstrate each absolute position and in IV) demonstrate the start, middle, and end distinctions. Red lettering in III) provides an example for SNV mutation site between reference and antigenic sequences.

Article Snippet: Predicted neoantigen peptides (MHC I: n = 210; MHC II: n = 68) were synthesized by New England Peptide (Gardner, MA), using custom peptide array technology ( Supplemental Data File 1 ).

Techniques: Immunopeptidomics, Enzyme-linked Immunospot, Biomarker Discovery, Sequencing, Mutagenesis

A) Schematic depicting pre-clinical trial workflow. B) Brightfield images of tumors isolated from vehicle and LDN214117 treated mice. C) Mean tumor volume from mice treated with vehicle (6 mice/group) and LDN214117 (7 mice/group). D) Graph depicting mean tumor weight from vehicle and LDN214117 treated mice. E) Western blot to assess BMP6 and hepcidin expression level in tumors from vehicle and LDN214117-treated mice. F) Representative images of immunohistochemistry for BMP6 and Hepcidin on tumor sections from mice treated with vehicle or LDN214117. F) Model depicting mechanism of altered iron homeostasis in LKB1-mutant tumor cells.

Journal: bioRxiv

Article Title: Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer

doi: 10.1101/2023.06.14.544941

Figure Lengend Snippet: A) Schematic depicting pre-clinical trial workflow. B) Brightfield images of tumors isolated from vehicle and LDN214117 treated mice. C) Mean tumor volume from mice treated with vehicle (6 mice/group) and LDN214117 (7 mice/group). D) Graph depicting mean tumor weight from vehicle and LDN214117 treated mice. E) Western blot to assess BMP6 and hepcidin expression level in tumors from vehicle and LDN214117-treated mice. F) Representative images of immunohistochemistry for BMP6 and Hepcidin on tumor sections from mice treated with vehicle or LDN214117. F) Model depicting mechanism of altered iron homeostasis in LKB1-mutant tumor cells.

Article Snippet: Hepcidin Antimicrobial Peptide antibody (NBP1-59337) was from Novus Biologicals.

Techniques: Isolation, Western Blot, Expressing, Immunohistochemistry, Mutagenesis